Publication | Open Access

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

OncologyMedicineColorectal CancerAdvanced Colorectal CarcinomaCancer TreatmentPharmacologyRadiation OncologyPrevious Treatment